Evaluation of novel concentrated interdisciplinary group rehabilitation for patients with chronic illnesses: Protocol for a nonrandomized clinical intervention study
Kvale, Gerd; Frisk, Bente; Jürgensen, Marte; Børtveit, Tore; Ødegaard-Olsen, Øystein Theodor; Wilhelmsen-Langeland, Ane; Aarli, Bernt Bøgvald; Sandnes, Kristina; Rykken, Sidsel; Haugstvedt, Anne; Hystad, Sigurd William; Søfteland, Eirik
Peer reviewed, Journal article
Published version
![Thumbnail](/hvlopen-xmlui/bitstream/handle/11250/2978161/Kvale.pdf.jpg?sequence=7&isAllowed=y)
Åpne
Permanent lenke
https://hdl.handle.net/11250/2978161Utgivelsesdato
2021Metadata
Vis full innførselSamlinger
- Import fra CRIStin [3621]
- Institutt for helse og funksjon [588]
Originalversjon
Kvale, G., Frisk, B., Jürgensen, M., Børtveit, T., Ødegaard-Olsen, Ø. T., Wilhelmsen-Langeland, A., . . . Søfteland, E. (2021). Evaluation of Novel Concentrated Interdisciplinary Group Rehabilitation for Patients With Chronic Illnesses: Protocol for a Nonrandomized Clinical Intervention Study. JMIR Research Protocols, 10(10): e32216. 10.2196/32216Sammendrag
Background:
An aging population with a growing burden of chronic complex illnesses will seriously challenge the public health care system. Consequently, novel and efficacious treatment approaches are highly warranted. Based on our experiences with concentrated treatment formats for other health challenges, we developed a highly concentrated interdisciplinary group rehabilitation approach for chronic illnesses.
Objective:
We aim to explore the acceptability of the intervention and describe potential changes in functional impairment at follow-up.
Methods:
The cornerstones of the intervention are as follows: (1) prepare the patient for change prior to treatment, (2) focus on health promoting microchoices instead of symptoms, and (3) expect the patient to integrate the changes in everyday living with limited hands-on follow-up. The intervention will be delivered to patients with highly diverse primary symptoms, namely patients with low back pain, post–COVID-19 symptoms, anxiety and depression, and type 2 diabetes.
Results:
Recruitment started between August 2020 and January 2021 (according to the illness category). For initial 3-month results, recruitment is expected to be completed by the end of 2021.
Conclusions:
If successful, this study may have a substantial impact on the treatment of low back pain, post–COVID-19 symptoms, anxiety and depression, and type 2 diabetes, which together constitute a major socioeconomic cost. Further, the study may widen the evidence base for the use of the concentrated treatment format in a diverse group of medical conditions.
International Registered Report Identifier (IRRID):
DERR1-10.2196/32216